Expert committee to review full market approval for Covishield, Covaxin

The Drugs Controller General of India (DCGI) is set to review full market approval for Covid-19 vaccines -- Covaxin and Covishield -- on Friday. The Subject Expert Committee (SEC) will hold a meeting around 2 pm to discuss the matter.

Both Covaxin and Covishield are currently only authorised for emergency use in the country.

The company, however, is yet to submit the full follow-up data of the clinical trial of Covaxin to DCGI, a source told news agency PTI on Thursday.

In October last year, Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), had submitted an application to the DCGI seeking regular market authorisation for Covishield.